<jvju class="fevjnx"></jvju>


江南·体育(JN SPORTS)官方网站,江南体育app下载

|
|
EN

  • 业务咨询

    中国：

    Email: marketing@hangzhouaijunshengwu.com

    业务咨询专线：400-780-8018

    （仅限服务咨询，其他事宜请拨打川沙总部电话）

    川沙总部电话: +86 (21) 5859-1500

    海外：

    +1(626)986-9880(U.S. - West Coast)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com
在线留言×
点击切换
Customer Center
客户中心

阿帕替尼通过VEGFR2通路抑制紫杉醇对胃癌细胞的耐药性

2023-07-05
|
访问量：

55.jpg

Overexpression of VEGFR2 can offset the rescue effect of Apatinib on Paclitaxel-induced drug resistance of MGC803 cells. Apatinib inhibits Paclitaxel resistance of MGC803 cells via the VEGFR2 signaling pathway.

In this research, the VEGFR2 sequences were designed and then amplified by RT-PCR. The sequences were then ligated with a pcDNA3.0 plasmid to construct a recombinant pcDNA3.0-VEGFR2 vector (Medicilon).

Reference:

Qian Xie, et al. Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway. Am J Transl Res. 2022 Jan 15;14(1):421-431. eCollection 2022.

相关新闻
江南·体育(JN SPORTS)官方网站